Search results
Biotech Stock Roundup: ICPT Up on Buyout Deal, IMVT & PLRX Gain on Study Data
Zacks via Yahoo Finance· 9 months agoIt was a busy week for the biotech sector, with a lot of important regulatory and pipeline updates....
Intercept (ICPT) Stock Down on FDA Committee Update on NDA
Zacks via Yahoo Finance· 1 year agoIntercept Pharmaceuticals, Inc. ICPT announced that the Gastrointestinal Drugs Advisory Committee...
Former Wall Street Darling Intercept Restructures After FDA Rejects Its Liver Drug
Investor's Business Daily· 1 year agoIntercept Pharmaceuticals said Friday it will restructure itself after the Food and Drug...
Intercept Pharmaceuticals Crashes After Drug Fails In Cirrhotic Patients
Investor's Business Daily· 2 years agoIntercept Pharmaceuticals' experimental NASH treatment failed in patients with liver cirrhosis,...
Biotech Stock Roundup: IRWD Announces Buyout, ICPT, SRPT & PTCT Fall on Updates
Zacks via Yahoo Finance· 1 year agoThe biotech sector has been in focus in the past week with key pipeline and regulatory updates....
Intercept Tumbles As Its Experimental NASH Drug Faces Yet Another Obstacle
Investor's Business Daily· 1 year agoIntercept Pharmaceuticals said Friday its experimental liver disease treatment will face a Food and...
The Zacks Analyst Blog Highlights Novavax, ALX Oncology, Regeneron Pharmaceuticals, Intellia and...
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – October 6, 2023 – Zacks.com announces the list of stocks...
Chemomab (CMMB) Mid-Stage Study for NASH Meets Primary Goal
Zacks via Yahoo Finance· 1 year agoChemomab Therapeutics, Ltd. CMMB announced that its mid-stage study evaluating CM-101 in...
Here's Why Hepion Pharma (HEPA) is Up More Than 80% in Two Days
Zacks via Yahoo Finance· 1 year agoHepion Pharmaceuticals' (HEPA) lead pipeline candidate, rencofilstat, demonstrates improvements in...